Corbus Pharmaceuticals Holdings (CRBP) Receivables - Other (2016 - 2021)

Corbus Pharmaceuticals Holdings' Receivables - Other history runs 5 years deep, the most recent figure standing at $2.5 million for Q3 2021.

• In Q3 2021, Receivables - Other rose 160.39% year-over-year to $2.5 million; the TTM figure through Sep 2021 stood at $2.5 million (up 160.39% YoY), while the FY2020 annual figure was $1.6 million, down 39.64% from the prior year.
• Receivables - Other was $2.5 million for Q3 2021 at Corbus Pharmaceuticals Holdings, up from $2.4 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $4.4 million in Q1 2020 to a low of $500000.0 in Q3 2017.
• Historically, Receivables - Other has averaged $2.2 million across 4 years, with a median of $2.3 million in 2021.
• Biggest YoY gain for Receivables - Other was 160.39% in 2021; the steepest drop was 49.0% in 2021.
• A 4-year view of Receivables - Other shows it stood at $500000.0 in 2017, then soared by 436.21% to $2.7 million in 2019, then slumped by 39.64% to $1.6 million in 2020, then surged by 54.48% to $2.5 million in 2021.
• The last three Receivables - Other figures came in at $2.5 million (Q3 2021), $2.4 million (Q2 2021), and $2.3 million (Q1 2021), per Business Quant data.